$ALLK 90 DAYS STOCK PRICE FORECAST
Stock Price
About the Company
Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The Company's lead antibody, lirentelimab (AK002), is being evaluated in a Phase 3 study in eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) and a Phase 2/3 study in eosinophilic esophagitis (EoE). Lirentelimab targets Siglec-8, an inhibitory receptor selectively expressed on human mast cells and eosinophils. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs. Lirentelimab has been tested in multiple clinical studies. In these studies, lirentelimab eliminated blood and tissue eosinophils, inhibited mast cells and improved disease symptoms in patients with EG and/or EoD, EoE, mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria and indolent systemic mastocytosis.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
125
Similar Companies
| Name | Ticker | Market Capitalization (USD M) | Revenue (USD M) | Price/Book | Price/Earning | Net Margin (%) |
|---|---|---|---|---|---|---|
| Charles River Laboratories Int | CRL | 21297 | 3273 | 9.08 | 53.74 | 12.10 |
| Exact Sciences Corp. | EXAS | 13407 | 1760 | 4.00 | -15.77 | -46.50 |
| PRA Health Sciences Inc | PRAH | 10739 | 3333 | 6.88 | 50.52 | 6.40 |
| Syneos Health Inc | SYNH | 10228 | 4980 | 3.04 | 40.93 | 5.04 |
| Medpace Holdings Inc | MEDP | 8027 | 1094 | 8.45 | 43.73 | 16.65 |
| Vir Biotechnology Inc | VIR | 6064 | 284 | 6.86 | -55.35 | -35.98 |
| Exelixis Inc | EXEL | 5081 | 1254 | 2.37 | 31.04 | 13.10 |
| Twist Bioscience Corp | TWST | 4280 | 127 | 7.36 | -32.52 | -106.59 |
| Allakos Inc | ALLK | 3929 | 7.67 | -17.95 | None | |
| Recursion Pharmaceuticals Inc | RXRX | 3213 | 10 | 5.37 | -21.85 | None |
| Sana Biotechnology Inc | SANA | 3212 | 3.99 | -8.95 | None | |
| Instil Bio Inc | TIL | 2808 | 0 | 4.67 | -23.66 | None |
| Allogene Therapeutics Inc | ALLO | 2539 | 38 | 2.80 | -10.15 | -652.24 |
| Lyell Immunopharma Inc | LYEL | 2282 | 10 | 2.32 | -11.06 | None |
| Erasca Inc | ERAS | 1806 | 3.81 | -11.16 | None | |
| Verve Therapeutics Inc | VERV | 1581 | 4.12 | -14.08 | None | |
| Constellation Pharmaceuticals | CNST | 1564 | 4.32 | -11.18 | None | |
| Pandion Therapeutics Inc | PAND | 1501 | 1069 | 1.83 | -13.34 | -10.55 |
| Sorrento Therapeutics Inc | SRNE | 1485 | 51 | 12.12 | -4.24 | -692.36 |
| Replimune Group Inc | REPL | 1419 | 2.85 | -14.34 | None | |
| Organogenesis Holdings Inc | ORGO | 1279 | 446 | 6.54 | 19.63 | 13.94 |
| Alx Oncology Holdings Inc | ALXO | 1240 | 1 | 3.26 | -21.24 | -401.23 |
| AlloVir Inc | ALVR | 1104 | 0 | 4.34 | -12.03 | -718.59 |
| National Research Corp | NRC | 1097 | 144 | 12.91 | 30.14 | 24.95 |
| Caribou Biosciences Inc | CRBU | 1081 | 8 | 2.68 | -17.15 | -787.07 |
| Rubius Therapeutics Inc | RUBY | 1066 | 4.98 | -5.84 | None | |
| Castle Biosciences Inc | CSTL | 1006 | 86 | 2.58 | -33.81 | -34.46 |
| Scholar Rock Holding Corp | SRRK | 927 | 18 | 4.83 | -7.55 | -672.72 |
| Crinetics Pharmaceuticals Inc | CRNX | 909 | 0 | 6.37 | -9.31 | -447.78 |
| Nuvalent Inc | NUVL | 907 | 3.03 | -23.92 | None | |
| Design Therapeutics Inc | DSGN | 870 | 0 | 2.25 | -31.00 | -245.44 |
| Omega Therapeutics Inc | OMGA | 851 | 3.85 | -14.90 | None | |
| Century Therapeutics Inc | IPSC | 841 | 1.98 | -10.06 | None | |
| RAPT Therapeutics Inc | RAPT | 837 | 4 | 4.72 | -13.20 | 7.14 |
| Icosavax Inc | ICVX | 823 | 7 | 2.82 | -15.51 | -723.56 |
| Tenaya Therapeutics Inc | TNYA | 814 | 2.70 | -14.38 | None | |
| Monte Rosa Therapeutics Inc | GLUE | 788 | 2.16 | -11.34 | None | |
| Tyra Biosciences Inc | TYRA | 783 | 2.54 | -38.96 | None | |
| Precigen Inc | PGEN | 770 | 99 | 6.33 | -7.00 | -109.91 |
| MeiraGTx Holdings plc | MGTX | 759 | 20 | 4.18 | -9.65 | -391.81 |
| Kezar Life Sciences Inc | KZR | 755 | 6.09 | -14.80 | None | |
| Sutro Biopharma Inc | STRO | 731 | 60 | 2.65 | -4.83 | -213.36 |
| Cullinan Oncology Inc | CGEM | 714 | 19 | 1.60 | -11.51 | -324.14 |
| Y-Mabs Therapeutics Inc | YMAB | 710 | 46 | 3.50 | -18.57 | -83.20 |
| Ideaya Biosciences Inc | IDYA | 705 | 36 | 2.59 | -20.16 | -103.19 |
| Imago BioSciences Inc | IMGO | 701 | -9.01 | -26.92 | None | |
| Janux Therapeutics Inc | JANX | 633 | 2 | 1.71 | -30.27 | -436.67 |
| Vera Therapeutics Inc | VERA | 599 | 7.09 | -10.33 | None | |
| Talaris Therapeutics Inc | TALS | 558 | 2.20 | -13.75 | None | |
| Immuneering Corp | IMRX | 530 | 3 | 3.34 | -18.54 | -887.28 |
| Graphite Bio Inc | GRPH | 514 | 1.29 | -8.53 | None | |
| Precision Biosciences Inc | DTIL | 497 | 118 | 5.22 | -15.03 | -26.91 |
| Vor Biopharma Inc | VOR | 480 | 2.08 | -6.90 | None | |
| Xilio Therapeutics Inc | XLO | 438 | -3.56 | -5.73 | None | |
| Evelo Biosciences Inc | EVLO | 420 | 13.30 | -3.44 | None | |
| Cortexyme Inc | CRTX | 417 | 3.13 | -4.73 | None | |
| Mirum Pharmaceuticals Inc | MIRM | 399 | 16 | 7.48 | -2.25 | None |
| Pyxis Oncology Inc | PYXS | 389 | -5.57 | -6.04 | None | |
| Werewolf Therapeutics Inc | HOWL | 370 | 2.23 | -1.95 | None | |
| Rallybio Corp | RLYB | 362 | 38 | 1.95 | -8.07 | -1.07 |
| Cue Biopharma Inc | CUE | 355 | 7 | 5.72 | -7.53 | -654.54 |
| Sera Prognostics Inc | SERA | 323 | 0 | 2.13 | -11.45 | None |
| Acumen Pharmaceuticals Inc | ABOS | 320 | 0 | 1.39 | -3.46 | -550.91 |
| Aerovate Therapeutics Inc | AVTE | 313 | 1.77 | -17.41 | None | |
| Biomea Fusion Inc | BMEA | 311 | 1.63 | -10.23 | None | |
| MiNK Therapeutics Inc | INKT | 298 | -5.49 | -16.64 | None | |
| Eliem Therapeutics Inc | ELYM | 295 | 1.71 | -5.18 | None | |
| Cabaletta Bio Inc | CABA | 289 | 2.81 | -6.96 | None | |
| Magenta Therapeutics Inc | MGTA | 288 | 1.71 | -4.13 | None | |
| Oyster Point Pharma Inc | OYST | 287 | 18 | 2.10 | -3.54 | -450.47 |
| Applied Therapeutics Inc | APLT | 285 | 14 | 3.44 | -2.75 | -19.41 |
| Candel Therapeutics Inc | CADL | 279 | 0 | 4.37 | -5.72 | None |
| Luna Innovations Inc | LUNA | 271 | 106 | 3.32 | -821.00 | -0.24 |
| Surface Oncology Inc | SURF | 253 | 90 | 1.98 | 10.05 | 14.33 |
| Compass Therapeutics Inc | CMPX | 247 | 8.47 | -3.04 | None | |
| Black Diamond Therapeutics Inc | BDTX | 224 | 1.03 | -1.83 | None | |
| Gemini Therapeutics Inc | GMTX | 211 | 1088 | 0.23 | 1.74 | 11.24 |
| Sensei Biotherapeutics Inc | SNSE | 209 | 1.33 | -6.36 | None | |
| Impel NeuroPharma Inc. | IMPL | 204 | 0 | 2.70 | -3.13 | None |
| Pieris Pharmaceuticals Inc | PIRS | 192 | 25 | 4.20 | -3.75 | -203.63 |
| INmune Bio Inc | INMB | 181 | 0 | 2.44 | -7.68 | None |
| Alzamend Neuro Inc | ALZN | 177 | 11.28 | -29.00 | None | |
| Nextcure Inc | NXTC | 168 | 22 | 0.67 | -2.44 | -163.57 |
| AquaBounty Technologies Inc | AQB | 162 | 1 | 0.83 | -6.76 | None |
| Tscan Therapeutics Inc | TCRX | 155 | 8 | 0.88 | -3.62 | -522.54 |
| Reneo Pharmaceuticals Inc | RPHM | 151 | 0.99 | -4.35 | None | |
| Elevation Oncology Inc | ELEV | 147 | 0.99 | -4.73 | None | |
| IN8bio Inc | INAB | 105 | 2.40 | -10.19 | None | |
| Unity Biotechnology Inc | UBX | 104 | 1 | 1.89 | -1.50 | None |
| Axcella Health Inc | AXLA | 104 | 2700 | 3.00 | -1.69 | -10.84 |
| HCW Biologics Inc | HCWB | 101 | 4 | 1.85 | -14.74 | -165.52 |
| BioVie Inc | BIVI | 98 | 7.14 | -0.79 | None | |
| Hookipa Pharma Inc | HOOK | 97 | 20 | 0.75 | -1.48 | -339.34 |
| Statera BioPharma Inc | STAB | 86 | 0 | None | -2.99 | None |
| Cyclerion Therapeutics Inc | CYCN | 73 | 4 | 1.52 | -1.21 | None |
| RenovoRx Inc | RNXT | 61 | 3.44 | -12.54 | None | |
| Synaptogenix Inc | SNPX | 53 | 1.67 | -3.51 | None | |
| NanoViricides Inc | NNVC | 50 | 1.85 | -5.55 | None | |
| Monopar Therapeutics Inc | MNPR | 48 | 2.39 | -5.69 | None | |
| Acurx Pharmaceuticals Inc | ACXP | 43 | 3.09 | -3.89 | None | |
| Eloxx Pharmaceuticals Inc | ELOX | 42 | 0 | 1.91 | -0.73 | -14.14 |
| Exicure Inc | XCUR | 41 | 4 | 1.12 | -0.87 | -148.49 |
| Vaccinex Inc | VCNX | 41 | 1 | 3.92 | -1.70 | -48.71 |
| Scopus Biopharma Inc | SCPS | 41 | 234 | 22.80 | -1.65 | 80.93 |
| TransCode Therapeutics Inc | RNAZ | 35 | 1.53 | -8.03 | None | |
| Rezolute Inc | RZLT | 35 | 3.16 | -1.46 | None | |
| Unicycive Therapeutics Inc | UNCY | 30 | 113 | 1.57 | -3.70 | 7.94 |
| Cyclo Therapeutics Inc | CYTH | 30 | 1 | 5.48 | -1.31 | -989.80 |
| Cytocom Inc | CBLI | 30 | 0 | 3.88 | -12.72 | -912.16 |
| CohBar Inc | CWBR | 29 | 2.96 | -1.69 | None | |
| AgeX Therapeutics Inc | AGE | 25 | 2 | -2.54 | -2.75 | -502.97 |
| Aridis Pharmaceuticals Inc | ARDS | 24 | 1 | -7.13 | -0.55 | -851.00 |
| Tenax Therapeutics Inc | TENX | 17 | 0 | 4.07 | -0.55 | -840.64 |
| Kiromic BioPharma Inc | KRBP | 17 | 7.37 | -1.17 | None | |
| Geovax Labs Inc | GOVX | 16 | 1 | 1.29 | -10.89 | -558.09 |
| Xenetic Biosciences Inc | XBIO | 11 | 1 | 0.84 | -2.26 | -510.87 |
| BioRestorative Therapies Inc | BRTX | 6 | 0 | -4.01 | -0.10 | None |
| Neurotrope Inc | NTRP | 5 | 29 | 0.08 | 0.76 | 23.48 |
Allakos Inc. (ALLK): Skating on Thin Ice? We Know the Answer
Allakos Inc. (NASDAQ:ALLK) went down by -4.03% from its latest closing price compared to the recent 1-year high of $157.98.
Allakos Inc. (ALLK): Ready for an explosive trading day
Let’s start up with the current stock price of Allakos Inc. (ALLK), which is $76.39 to be very precise. The Stock rose vividly during the last session to $81.405 after opening rate of $79.60 while the ...
Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma
Nov. 30, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast ...
Do Options Traders Know Something About Allakos (ALLK) Stock We Don't?
Disclaimer | Accessibility Statement | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Investors in Allakos Inc. ALLK need to pay close attention to the stock based on moves in the ...
Noteworthy Tuesday Option Activity: ALLK, FDX, SWBI
A mong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Allakos Inc ...
Expanded cancer ADC deal between Synaffix and Mersana could be worth $1B
Amsterdam’s Synaffix BV has expanded a deal focusing on its antibody-drug conjugate (ADC) linker tech with U.S. cancer biotech Mersana Therapeutics Inc., with the revised contract potentially paying ...
Do Options Traders Know Something About Allakos (ALLK) Stock We Don't?
Investors in Allakos Inc. ALLK need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $60.00 Put had some of the highest implied ...
Do Options Traders Know Something About Allakos (ALLK) Stock We Don't?
Investors in Allakos Inc. ALLK need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $60.00 Put had some of the highest implied ...